ACAD - acadia-pharm.com Operating profit before amortization
Risks for ACADIA Pharmaceuticals (ACAD) are linked to vulnerability to generics and a limited portfolio of approved drugs. The change in EBITDA visualizes cash flow before taxes, and the value of 136.52 confirms the current profit level. ACADIA Pharmaceuticals relies on biotech patent protection to monopolize its niche, seeking to reduce dependence on a single drug by launching therapies for rare neurological pathologies.
%20Operating%20profit%20EBITDA&width=1200&height=400&colorIndex=0&v=mwa76aez.ocr-7cpmfb4&start=20220704&end=20261110&filename=GURU_Markets_-_ACAD_-_ACADIA-Pharmaceuticals_-_Operating-profit-EBITDA "ACADIA Pharma - ACAD Operating income before deduction of amortization (period 11/23/2025 - 11/10/2026) | 👁️GURU.Markets👁️")
Summary analytical data breakdowns for ACADIA Pharmaceuticals Inc. (ACAD)
- market price and analyst price targets:
- market capitalization statistics:
- balance sheet net asset value indicators:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio ACADIA Pharmaceuticals|ACAD - Long-Term Debt to Equity|Current Liabilities to Equity ACADIA Pharma|ACAD - Company Aggregate Debts|Debt to Net Assets Ratio ACADIA Pharmaceuticals|ACAD - Company Long-Term Debts|Company Short-Term Debts ACADIA Pharmaceuticals|Intermediate Coverage Ratio acadia-pharm.com
- company profitability and valuation multiples indicators:
ACAD - Company Net Income|Future Profit ACADIA Pharmaceuticals|ACAD - P/E Multiple|Forward P/E Multiple acadia-pharm.com|ACAD - PEG Multiple|Enterprise Value to EBITDA Ratio ACADIA Pharmaceuticals|ACAD - Operating profit EBITDA|Net earnings per one share for the last twelve months ACADIA Pharmaceuticals|ACAD - Net earnings per share for the last 12 months|Quarterly EPS earnings growth acadia-pharm.com|ACAD - Net earnings per share growth this year|Projected earnings per share increase next year ACADIA Pharmaceuticals
Summary company analytics:ACADIA Corp
Bioscreening automation and AI-driven genetic analysis at ACADIA Pharmaceuticals (ACAD) are reducing operating expenses, directly impacting cash flow from operating activities. This metric captures the actual cash inflow before taxes and interest, allowing investors to assess business efficiency without GAAP non-cash adjustments, which is clearly reflected in the projected EBITDA level.
Who ACADIA Pharmaceuticals competes with
Operating profit EBITDA Biogen Idec BIIB|Neurocrine Biosciences - Operating profit EBITDA|RGC (regencellbioscience.com) - Operating profit before amortization|AXSM: Operating profit EBITDA|XENE - Operating income before deduction of amortization|VKTX (Viking Pharma) - Operating profit EBITDA|Operating profit EBITDA Supernus Corp|Operating profit before deduction of amortization CPRX (Catalyst Pharmaceuticals)|DNLI (denalitherapeutics.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Harmony Biosciences Holdings, Inc. HRMY|BHVN (Biohaven Ltd) - Profit before deduction of interest, taxes, depreciation and amortization|Amylyx - Operating profit EBITDA|Income before deduction of interest, taxes and amortization TRVI (Trevi Corp)|PRAX: Operating profit EBITDA|anavex.com (AVXL) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization CeriBell|PRTA: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Alector, Inc. (ALEC)|Operating profit before deduction of amortization Annexon Biosciences Inc. ANNX|Operating profit EBITDA OMER (Omeros)|Operating profit EBITDA neurogene.com NGNE|AC Immune SA - Operating profit EBITDA|Voyager Therapeutics Inc (VYGR) - Operating profit before deduction of amortization|NMRA: Operating profit EBITDA|Profit before interest, taxes and amortization Scilex Holding Company, Inc. (SCLX)|Operating profit before deduction of amortization TVGN|Operating profit EBITDA Alpha Cognition Corp|Operating profit before deduction of amortization CGTX (Cognition Therapeutics, Inc.)|Company profit before taxes, interest and amortization IKT|Operating profit EBITDA SAVA (Cassava)|Operating income before deduction of amortization Assertio Holdings (ASRT)|Coya - Operating profit EBITDA|Vistagen Therapeutics (VTGN) - Operating profit before deduction of amortization|OVID: Operating profit EBITDA|Acumen Pharmaceuticals Inc. (ABOS) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization CervoMed Inc|Profit before payment of interest, taxes and amortization ATHE|Profit before payment of interest, taxes and amortization Clene Inc. (CLNN)|Operating income before deduction of amortization pepgen.com|Operating profit EBITDA JUNS (Jupiter Neurosciences)|Operating profit EBITDA Relmada Therapeutics Inc RLMD|Annovis Bio Corp - Operating profit EBITDA|Grace Therapeutics, Inc. (GRCE) - Operating profit before deduction of amortization|AIFF: Operating profit EBITDA|Klotho Neurosciences (KLTO) - Operating profit EBITDA|NRSN (NeuroSense Therapeutics Ltd) - Operating profit EBITDA|Operating profit before amortization RVPH (Reviva Pharmaceuticals Holdings Inc.)|Profit before payment of interest, taxes and amortization MetaVia Inc (MTVA)|NeurAxis Inc - Operating profit before amortization|Operating profit EBITDA HSDT (Helius Medical Technologies)|Passage Bio Inc. (PASG) - Profit before interest, taxes and amortization|NEUP: Operating profit before deduction of amortization|NERV - Operating profit EBITDA|Athira (ATHA) - Profit before payment of interest, taxes and amortization|Addex - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Alzamend Neuro Inc.|Profit before interest, taxes and amortization Cyclerion CYCN|Operating profit EBITDA PTIX|Operating profit EBITDA pasitheaclinics.com (KTTA)|Operating profit EBITDA CRGT (Cortigent)|ATXI - Operating profit before deduction of amortization|Brainstorm Cell - Operating profit EBITDA|CARA - Operating profit EBITDA|CHRO: Operating profit EBITDA|Operating profit before amortization ELYM|ITCI (Intra-Cellular Therapies Inc.) - Operating profit EBITDA|Longboard (LBPH) - Operating income before deduction of amortization|Operating profit EBITDA MRNS|Operating profit EBITDA nkgenbiotech.com (NKGN)|NeuroBo Pharmaceuticals, Inc. - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization SAGE|SNPX - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization TRVN|VIGL: Operating profit EBITDA|anewmeds.com - Income before deduction of interest, taxes and amortization|CERE (Cerevel Therapeutics, Inc.) - Operating profit EBITDA
